Treatment of hypertension in older persons: what is the evidence?
- PMID: 24668034
- DOI: 10.1007/s40266-014-0171-7
Treatment of hypertension in older persons: what is the evidence?
Abstract
Evidence for treatment of hypertension in older people is limited to placebo-controlled studies that reduced blood pressure in persons over 60 years who had systolic blood pressure >160 mmHg. Generally, physicians measure blood pressure poorly, failing to look for white coat or masked hypertension, orthostasis, postprandial hypotension, or pseudohypertension. There is evidence that if 24-hour ambulatory blood pressures were obtained, the treatment goal should be substantially lower. Sleep apnea, pain, nocturnal hypoglycemia, drugs, excess aldosterone production, and pheochromocytoma should all be considered as causes of hypertension in older persons. Evidence supports a low-dose diuretic or an angiotensin converting enzyme inhibitor as appropriate first-line therapies in older persons.
Similar articles
-
Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.Clin Exp Hypertens. 2001 Apr;23(3):203-11. doi: 10.1081/ceh-100102660. Clin Exp Hypertens. 2001. PMID: 11339687
-
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].Rev Port Cardiol. 1999 Oct;18(10):897-906. Rev Port Cardiol. 1999. PMID: 10590654 Portuguese.
-
'Reverse white-coat hypertension' in older hypertensives.J Hypertens. 2002 Apr;20(4):639-44. doi: 10.1097/00004872-200204000-00020. J Hypertens. 2002. PMID: 11910298 Clinical Trial.
-
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.Can J Cardiol. 2010 May;26(5):249-58. doi: 10.1016/s0828-282x(10)70379-2. Can J Cardiol. 2010. PMID: 20485689 Free PMC article. Review.
-
Management of hypertension in older persons.Am Fam Physician. 2005 Feb 1;71(3):469-76. Am Fam Physician. 2005. PMID: 15712622 Review.
Cited by
-
Editorial: Frailty and Polypharmacy.J Nutr Health Aging. 2016;20(6):645-6. doi: 10.1007/s12603-015-0510-3. J Nutr Health Aging. 2016. PMID: 27273354 No abstract available.
-
Polypharmacy Is Significantly and Positively Associated with the Frailty Status Assessed Using the 5-Item FRAIL Scale, Cardiovascular Health Phenotypic Classification of Frailty Index, and Study of Osteoporotic Fractures Scale.J Clin Med. 2021 Sep 26;10(19):4413. doi: 10.3390/jcm10194413. J Clin Med. 2021. PMID: 34640429 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical